What does a positive Hepatitis B (HB) surface antibody (HBsAb) with negative Hepatitis B surface antigen (HBsAg) and negative Hepatitis B core antibody (HBcAb) indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis B Surface Antibody Positive with Negative Surface Antigen and Core Antibody

This serologic pattern (HBsAg negative, HBsAb positive, HBcAb negative) indicates immunity to hepatitis B virus from successful vaccination, not from natural infection. 1, 2

What This Pattern Means

  • You have vaccine-derived immunity to hepatitis B. The Centers for Disease Control and Prevention confirms that this specific combination—negative HBsAg, positive HBsAb, and negative HBcAb—is the hallmark serologic pattern of successful hepatitis B vaccination. 1

  • You are protected against hepatitis B infection. The presence of HBsAb at levels ≥10 mIU/mL indicates protective immunity, and you cannot transmit hepatitis B to others because you have never been infected with the virus. 1, 2

  • The absence of HBcAb is the key distinguishing feature. Detection of HBsAb without HBcAb specifically distinguishes vaccine-derived immunity from immunity acquired through natural infection (which would show positive HBcAb). 2

Clinical Significance

  • No active or past infection exists. You have never been infected with hepatitis B virus—the immunity comes solely from vaccination. 1

  • You are not infectious and pose no transmission risk to others, as confirmed by the negative HBsAg. 1

  • No further routine testing is typically required in immunocompetent individuals, though annual screening with anti-HBs may be recommended in certain high-risk settings like dialysis units. 3

Special Considerations for Immunosuppression

  • If you require immunosuppressive therapy (such as chemotherapy, anti-CD20 monoclonal antibodies like rituximab, or high-dose corticosteroids), you should be monitored for potential loss of immunity. 1

  • The risk of HBV reactivation is minimal in individuals with vaccine-derived immunity because you lack HBcAb, meaning there is no prior natural infection that could reactivate. 1

  • This is fundamentally different from patients with resolved natural infection (who would be HBsAg negative, HBsAb positive, and HBcAb positive), who carry a 3-45% risk of HBV reactivation with immunosuppressive therapy. 3, 4

Common Pitfalls to Avoid

  • Do not confuse this pattern with resolved natural infection. Resolved infection would show positive HBcAb in addition to positive HBsAb—the negative HBcAb in your case definitively indicates vaccination rather than past infection. 2

  • Transient false-positive HBsAg can occur up to 18 days after vaccination (up to 52 days in hemodialysis patients), but this does not apply to your situation since your HBsAg is negative. 2

  • Passively acquired antibodies from blood product transfusion can rarely cause positive HBsAb without true immunity, but this is uncommon and typically occurs shortly after transfusion. 5

References

Guideline

Interpretation of Hepatitis B and C Serology Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hepatitis B Surface Antigen and Antibody Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Interpretation of Hepatitis B Surface Antigen Non-reactive & Reactive Hepatitis B Core Antibody

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.